Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Aussie of the Year announces new vaccine trial

08.02.2006


The technology used in the world’s first cervical cancer vaccine will be tweaked to fight the most common sexually transmitted disease, genital warts.



Australian of the Year and University of Queensland (UQ) cervical cancer vaccine creator Professor Ian Frazer launched a therapeutic vaccine trial for genital warts today (Tuesday, February 7).

Patients from Brisbane and China will take part in the joint project for UQ’s cancer research centre, the Centre for Immunology and Cancer Research (CICR) and the hospital’s sexual health service, Princess Alexandra Sexual Health (PASH).


Professor Frazer said the vaccine used virus-like particles to deliver an antigen (protein that produces immunity) for genital warts similar to the cervical cancer vaccine.

"It will target the main causes of visible genital warts which are human papillomavirus (HPV6) and (HPV11)," Dr Frazer said.

A pilot study of vaccine CICRVAX6 by UQ’s Chinese research partner, Wenzhou Medical College, showed the vaccine was potentially effective at treating genital warts in humans.

Now PASH is running a larger trial and needs 120 men and 120 women who have recurring genital warts.

Participants must be aged between 18 and 65 years, should not be pregnant or immunosuppressed and will be required for seven medical visits, with their travel costs refunded.

Trial Manager and PASH Senior Medical Officer Dr David Jardine said patients would receive standard treatment for genital warts and two vaccine shots, which are saline solutions injected in the upper arm, over two months.

"The incentives for people are that they get free consultations, free treatment, free vaccines and their travelling expenses paid," Dr Jardine said.

He said conventional wart treatments of freezing, burning or painting visible warts with acid might not switch off the active infection.

The 18-month trial will be launched in conjunction with Wartfest, an annual expo about new developments and treatments for warts, HPV and cancer, featuring expert speakers from Australia and Canada.

Genital warts are transmitted by skin contact and the 2003 Australian Study of Sex and Relationships of 20,000 adults revealed four percent of people had had visible genital warts.

Professor Frazer said developing a preventative warts vaccine or a combined vaccine for cervical cancer and genital warts was one of the next steps if the therapeutic trial was successful.

Miguel Holland | EurekAlert!
Further information:
http://www.researchaustralia.com.au
http://www.cicr.uq.edu.au

More articles from Health and Medicine:

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

nachricht New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>